Anti-inhibitor coagulant complex and Charcoal, Activated

• Generic Name: anti-inhibitor coagulant complex
• Dosage Forms: n.a.
• Other Brand Names: Feiba, Feiba VH Immuno, Autoplex T, Feiba NF

Anti-inhibitor coagulant complex is used in people who have hemophilia and have developed antibodies to clotting factor medications.

Hemophilia, an inherited blood-clotting disorder, is often treated with medicines containing clotting factors that help control bleeding. When the body develops antibodies or "inhibitors" to the clotting factor, this treatment becomes less effective in preventing bleeding episodes. Anti-inhibitor coagulant complex works by bypassing the effects of these inhibitors to improve blood clotting and decrease the risk of bleeding.

Anti-inhibitor coagulant complex is used to treat or prevent bleeding episodes in people with hemophilia A or B who have developed inhibitors. anti-inhibitor coagulant complex is also used to control bleeding related to surgery in people with hemophilia and inhibitors. Anti-inhibitor coagulant complex is not for treating bleeding episodes in people who do not have inhibitors.

Anti-inhibitor coagulant complex may also be used for purposes not listed in this medication guide.

• Generic Name: charcoal
• Dosage Forms: n.a.
• Other Brand Names: Actidose-Aqua, Activated Charcoal, Charcoal Plus DS, EZChar, Insta-Char, Liqui-Char, Optimum Charcoal, Liqui-Char with Sorbitol, Charcocaps, Activated Charcoal with Sorbitol, Charcoaid 2000, Charcoaid-G, Char-Flo with Sorbitol, Charcoaid, Charcodote, Char-Flo Aqueous Base, Actidose-Aqua Advance, JL. Bragg's Medicinal Charcoal, Medicoal, Karbons, Carbomix, Carbosorb X, Charcotabs, Healthstream Activated Charcoal, Charcotrace, Chem Mart Nasal Decongestant Capsule, Pharmacia Carbosorb, Norit, Eucarbon, Active Carbon

May be used for treatment (GI decontamination) in most oral poisonings except those involving corrosive agents (e.g., strong acids or alkalis) or substances for which its absorptive capacity is too low to be clinically useful (e.g., iron salts, lithium, boric acid, arsenic, malathion, or organic solvents such as methanol, ethanol, or ethylene glycol).

Most commonly used agent for GI decontamination in poisoned patients; however, routine administration in poisoned patients is not recommended by American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists (AACT/EAPCCT). Controlled studies demonstrating reduced morbidity and mortality generally are lacking. (See General: Poisonings, under Dosage and Administration.)

Hemoperfusion through columns of activated charcoal to remove endogenous or exogenous toxins in uremia, hepatic failure, or acute toxicity associated with overdose of certain drugs.

Adsorption of intestinal gases in the treatment of flatulence, intestinal distention, and dyspepsia; FDA classified as lacking substantial evidence of efficacy as antiflatulent or digestive aid.

Has been used alone or combined with kaolin in the management of diarrhea, but value has not been established.

Has been used in dressings for suppurating wounds or ulcers to decrease odor and promote healing.